Dr. Rowan Chapman is a partner at Mohr Davidow Venture Capital firm. She is a board member of Sequenta and VitaPath Genetics, as well as a board observer at Artemis Health, HealthTap, Pacific Biosciences, Adamas Pharmaceuticals, CardioDx, and Tethys Bioscience.Dr. Rowan Chapman was also a postdoctoral fellow at UCSF, as well as at the MRC-Laboratory of Molecular Biology at Cambridge. She holds a Ph.D. in cellular and molecular biology from the MRC Laboratory of Molecular Biology in Cambridge University. She likes to point out that she sequenced by hand in the dark ages prior to any genome sequencing or access to automated technologies, and never wants to pour a sequencing gel again!
Time: 5:30PM, Tuesday 1/24/201Location: TBD (Mission Bay)More details to come